Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Patrice Hugo, Ph.D. | May 18, 2016

Genomics enhances Clinical Immuno-oncology Trials

Immuno-oncology is developing at an unprecedented rate, with information integrated into drug development almost simultaneously. Accelerated bench-to-bedside practice brings great opportunity, but challenges emerge in the application of genomics to clinical trials. This presentation discusses test services developed by Q² Solutions to enable translation of Immuno-oncology genomics in clinical trials.
Personalizing oncology with genomics

Next-generation sequencing will transform oncology clinical trials and treatments for cancer

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More